Aggressive behavior of epilepsy patients in the course of levetiracetam add-on therapy: report of 33 mild to severe cases
Authors:
- Vera DinkelackerVDVera Dinkelacker
- Thomas DietlTDThomas Dietl
- Guido WidmanGWGuido Widman
- Ulrike LenglerULUlrike Lengler
- Christian E ElgerCEChristian E Elger
- 1 October 2003
- journal article
- case report
- Published by Elsevier in Epilepsy & Behavior
- Vol. 4 (5) , 537-547
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Safety Profile of LevetiracetamEpilepsia, 2001
- The Place of Levetiracetam in the Treatment of EpilepsyEpilepsia, 2001
- Efficacy of Levetiracetam: A Review of Three Pivotal Clinical TrialsEpilepsia, 2001
- Efficacy and tolerability of 1000–4000 mg per day of levetiracetam as add-on therapy in patients with refractory epilepsyEpilepsy Research, 2000
- Efficacy and Tolerability of Levetiracetam 3000 mg/d in Patients with Refractory Partial Seizures: A Multicenter, Double‐Blind, Responder‐Selected Study Evaluating MonotherapyEpilepsia, 2000
- Multicenter Double‐Blind, Randomized, Placebo‐Controlled Trial of Levetiracetam as Add‐On Therapy in Patients with Refractory Partial SeizuresEpilepsia, 2000
- Levetiracetam for partial seizuresNeurology, 2000
- A multicentre, double-blind, randomized, parallel group study to evaluate the tolerability and efficacy of two oral doses of levetiracetam, 2000 mg daily and 4000 mg daily, without titration in patients with refractory epilepsySeizure: European Journal of Epilepsy, 2000
- Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsyEuropean Journal of Pharmacology, 1998
- The novel antiepileptic drug levetiracetam (ucb L059) appears to act via a specific binding site in CNS membranesEuropean Journal of Pharmacology, 1995